Clinical Trials
7 trialsNCT02499783 2019-01-04
Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease
AbbVie
Phase 3 Completed
NCT00552058 2018-08-09
Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease
UCB Pharma
Phase 3 Completed
NCT00333788 2018-08-07
Welcome2
UCB Pharma
Phase 3 Completed
NCT01369329 2016-12-07
A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
Janssen Research & Development, LLC
Phase 3 Completed
NCT00354367 2012-05-28
Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas
UCB Pharma
Phase 3 Withdrawn
NCT00358683 2012-05-28
A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease
UCB Pharma
Phase 3 Withdrawn
NCT00297648 2011-08-31
MUSIC
UCB Pharma
Phase 3 Completed